Plasma concentrations of all three immunomodulatory proteins (galectin-1, alpha-1-microglobulin, and galectin-9) were independently associated with 2-year MACE in the patients with PAD even after adjusting for all the baseline demographic and clinical characteristics (Table 4). This evidence concerns the gene LGALS9 and peripheral arterial disease.